Adjuvant chemoradiation in resected gallbladder cancer: a prognostic index model for predicting overall survival

被引:1
|
作者
Sole, Claudio V. [1 ,2 ,3 ,4 ]
Vargas, Lorena [1 ,2 ,3 ]
Sole, Vicente J. [5 ]
Larsen, Francisco [1 ,2 ,3 ]
Sole, Sebastian [1 ,2 ,3 ]
机构
[1] Inst Radiomed, Dept Radiat Oncol, Ave Amer Vespucio Norte 1314, Santiago 7630370, Chile
[2] Inst Radiomed, Radiat Med Program, Santiago, Chile
[3] Diego Portales Univ, Sch Med, Santiago, Chile
[4] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain
[5] San Sebastian Univ, Sch Med, Santiago, Chile
关键词
Gallbladder cancer; Radiotherapy; Overall survival; BEAM RADIATION-THERAPY; CONCURRENT CHEMOTHERAPY; CHEMORADIOTHERAPY; RADIOTHERAPY; CARCINOMA;
D O I
10.1007/s13566-019-00382-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposePatients with gallbladder cancer (GBC) have a dismal prognosis. We investigated outcomes and risk factors for overall survival (OS) in patients treated with radical surgery and adjuvant chemoradiotherapy (CRT).Materials/methodsA total of 212 patients with LAGC (pT3 59% and/or pN+ 52%) were studied. The primary endpoint of the analysis was OS. We constructed a risk scoring system in which points were assigned to each risk factor by dividing each beta coefficient in the final model by the lowest beta coefficient and rounding to the nearest integer. A risk score was assigned to each subject by adding up the points for each risk factor present. Subjects were then divided into three risk groups based on their risk scores (0 points=low risk, 1-2 points=intermediate risk, 3-6 points=high risk).ResultsMedian follow-up was 46.2months (2-235). Five-year OS for the entire cohort was 53%. In multivariate analysis, higher pT stage [HR, 2.43 (1.29-3.68); p=0.01], R1 resection [HR, 5.06 (3.12-8.19); p<0.001], and number of surgical procedures [HR, 1.41 (1.01-2.16); p=0.05] were associated with an increased risk of death. Five-year OS for patients with low (n=63), intermediate (n=94), and high (n=55) risk was 79.1%, 51.2%, and 9.5%, respectively.ConclusionOverall results after multimodality treatment of GBC are promising. A risk model was generated to determine a prognostic index for individual patients with GBC. Classification of risk factors for death has contributed to propose a prognostic index that could allow us to guide risk-adapted tailored treatment.
引用
收藏
页码:157 / 162
页数:6
相关论文
共 50 条
  • [1] Adjuvant chemoradiation in resected gallbladder cancer: A prognostic model for overall survival
    Sole, C.
    Vargas, L.
    Sole, V.
    Larsen, F.
    Sole, S.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S407 - S407
  • [2] Adjuvant chemoradiation for resected gallbladder cancer
    Muller, B. G.
    Sola, J. A.
    Carcamo, M.
    Sola, A.
    Ciudad, A. M.
    Trujillo, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [3] Nomogram for Predicting the Benefit of Adjuvant Chemoradiotherapy for Resected Gallbladder Cancer
    Wang, Samuel J.
    Lemieux, Andrew
    Kalpathy-Cramer, Jayashree
    Ord, Celine B.
    Walker, Gary V.
    Fuller, C. David
    Kim, Jong-Sung
    Thomas, Charles R., Jr.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (35) : 4627 - 4632
  • [4] A regression model for predicting the survival benefit of adjuvant radiotherapy for gallbladder cancer
    Wan, S. J.
    Fuller, C. D.
    Sanglivi, P. R.
    Patel, K. M.
    Thomas, C. R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S550 - S551
  • [5] Development and External Validation of a Model to Predict Overall Survival in Patients With Resected Gallbladder Cancer
    Lohman, Elise A. J. de Savornin
    de Bitter, T. J. J.
    Hannink, G.
    Wietsma, M. F. T.
    Vink-Borger, E.
    Nagtegaal, I. D.
    Hugh, T. J.
    Gill, A. J.
    Bhimani, N.
    Ahadi, M. Seyed
    van der Post, R. S.
    de Reuver, Philip R.
    [J]. ANNALS OF SURGERY, 2023, 277 (04) : e856 - e863
  • [6] Survival After Chemoradiation in Resected Pancreatic Cancer: The Impact of Adjuvant Gemcitabine
    Baschnagel, Andrew
    Shah, Chirag
    Margolis, Jeffrey
    Nadeau, Laura
    Stein, Julie
    Jury, Robert
    Robertson, John M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (03): : E331 - E335
  • [7] Analysis of the Effect of Adjuvant Therapy on Overall Survival for Resected Gallbladder Adenocarcinoma Using the National Cancer Data Base
    Brauer, D.
    Lim, K.
    Doyle, M.
    Hawkins, W.
    Chapman, W.
    Fields, R.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S103 - S103
  • [8] Analysis of the effect of adjuvant therapy on overall survival for resected gallbladder adenocarcinoma using the National Cancer Database.
    Brauer, David G.
    Lim, Kian-Huat
    Doyle, Maria Majella
    Hawkins, William G.
    Chapman, William C.
    Fields, Ryan C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [9] Comment on: development and external validation of a model to predict overall survival in patients with resected gallbladder cancer
    Chakrabarti, Sakti
    Mahipal, Amit
    [J]. HEPATOBILIARY SURGERY AND NUTRITION, 2022, 11 (01) : 136 - 138
  • [10] Patients With Resected Gallbladder Cancer Demonstrate Improved Survival With Adjuvant Therapy
    Hoehn, Richard S.
    Wima, Koffi
    Ertel, Audrey
    Meier, Alexandra
    Ahmad, Syed
    Shah, Shimul A.
    Abbott, Daniel E.
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S1110 - S1110